Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Molecular profiles of endometrial cancer tumors among Black patients
Annelise M. Wilhite
, Yasmine Baca
, Joanne Xiu
, Rajesh Paladugu
, Adam C. ElNaggar
, Jubilee Brown
, Ira S. Winer
, Robert Morris
, Britt K. Erickson
, Alexander B. Olawaiye
,
Matthew Powell
, W. Michael Korn
, Rodney P. Rocconi
,
Dineo Khabele
, Nathaniel L. Jones
Department of Obstetrics & Gynecology
Institute of Clinical and Translational Sciences (ICTS)
Division of Gynecologic Oncology
Siteman Cancer Center
School of Medicine
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
DBBS - Molecular Cell Biology
DBBS - Molecular Genetics and Genomics
DBBS - Biochemistry, Biophysics, and Structural Biology
DBBS - Cancer Biology
Intellectual and Developmental Disabilities Research Center (IDDRC)
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Research output
:
Contribution to journal
›
Article
›
peer-review
22
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Molecular profiles of endometrial cancer tumors among Black patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Tumor
100%
Black Men
100%
Endometrial Cancer
100%
Molecular Profile
100%
Tumor
66%
Black Women
66%
White Patients
33%
Carcinosarcoma
33%
Endometrioid
33%
Proportion of Tumour
33%
Histology
16%
Clinical Trials
16%
TP53 mutation
16%
No Significant Difference
16%
Targeted Therapy
16%
Gene mutation
16%
Serous Tumor
16%
Personalized Medicine
16%
Histologic
16%
Histological Subtypes
16%
Microsatellite Instability-high (MSI-H)
16%
Tumor mutation Burden
16%
White Women
16%
Life Sciences
16%
Mismatch Repair
16%
Molecular Profiling
16%
Serous Histology
16%
ARID1A
16%
Tumor Analysis
16%
Self-reported Race
16%
Hormone Receptor Expression
16%
Tumor Profiling
16%
Tumor Molecular Profiling
16%
TMB-H
16%
Medicine and Dentistry
Tumor
100%
Uterine Cancer
100%
Neoplasm
22%
Carcinosarcoma
22%
Molecular Profiling
22%
Clinical Trial
11%
Targeted Therapy
11%
Gene Mutation
11%
Personalized Medicine
11%
Receptor Expression
11%
Hormone Receptor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Endometrium Cancer
100%
Neoplasm
50%
Carcinosarcoma
50%
Clinical Trial
25%
Hormone Receptor
25%